Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.92
-0.06 (-0.75%)
Nov 21, 2024, 11:58 AM EST - Market open
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $45.09M in the quarter ending September 30, 2024, with 10.62% growth. This brings the company's revenue in the last twelve months to $202.86M, up 16.14% year-over-year. In the year 2023, Treace Medical Concepts had annual revenue of $187.12M with 31.92% growth.
Revenue (ttm)
$202.86M
Revenue Growth
+16.14%
P/S Ratio
2.44
Revenue / Employee
$393,141
Employees
516
Market Cap
493.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
Dec 31, 2019 | 39.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Esperion Therapeutics | 295.45M |
Pacific Biosciences of California | 173.15M |
Arcturus Therapeutics Holdings | 160.40M |
GRAIL | 117.67M |
Y-mAbs Therapeutics | 84.55M |
REGENXBIO | 84.33M |
Theravance Biopharma | 63.19M |
Zevra Therapeutics | 24.49M |
TMCI News
- 22 hours ago - The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations - Accesswire
- 1 day ago - Treace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm - Accesswire
- 2 days ago - Treace Announces Participation at Stifel 2024 Healthcare Conference - GlobeNewsWire
- 3 days ago - The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Treace Medical Concepts Inc For Securities Law Violations - Accesswire
- 3 days ago - Treace Medical Concepts, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 4 days ago - The Schall Law Firm Wants Shareholders To Join An Inquiry Into Treace Medical Concepts Inc For Violating Securities Regulations - Accesswire
- 6 days ago - The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations - Accesswire
- 7 days ago - Treace Medical Concepts Inc Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Help The Schall Law Firm - Accesswire